Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (142)
  • Testimony (88)
  • Microgram (49)
  • DEA Administrator Remarks (29)
  • Speech (21)
  • In the News (5)
  • Announcements (3)

Publication Type

  • Intelligence (72)
  • DEA Administrator (39)
  • Forensics: Quality Management System Documents (32)
  • Drug Prevention (25)
  • Forensics (10)
  • Announcement (3)
  • Recruitment (1)

Drug Name

  • Narcóticos (opioides) (23)
  • Fentanyl (13)
  • Methamphetamine (10)
  • Drugs of Concern (7)
  • Heroin (7)
  • Cannabis (5)
  • Xylazine (5)
  • Marijuana (4)
  • Cocaine (2)
  • Synthetic Opioids (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Ketamine (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)

Topic

  • Forensics: Quality Management System Documents (30)
  • Forensic Sciences (8)
  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
340 Results - Showing 121 to 130
DOCUMENT
|
Publication

DEA 360 Strategy Reach and Impact Report: NEWARK

Enero 21, 2020
This report describes the methods and results of an assessment of the reach and impact of community outreach activities of the DEA 360 Strategy in Newark. Results are based on a summary of metrics compiled from each program facilitator, as well as from interviews with community partners from across the...
Enero 21, 2020
DOCUMENT
|
Testimony

Statement of the Drug Enforcement Administration before the House Committee on Energy and Commerce-Subcommittee on Health for a Hearing Entitled: Cannabis Policy-For The New Decade

Enero 15, 2020
Matthew J. Strait, Senior Policy Advisor, Diversion Control Division-DEA; Before the House Energy and Commerce Committee-Subcommittee on Health, for a Hearing Entitled: Cannabis Policy-For the New Decade
Enero 15, 2020
DOCUMENT
|
Publication

Prevention with a purpose

Enero 01, 2020
A strategic planning guide for preventing drug misuse among college students.
Enero 01, 2020
DOCUMENT
|
Testimony

Statement of the USDOJ Amanda Liskamm Director Opioid Enforcement and Prevention Efforts Office of the Deputy Attorney General Tim Mcdermott Assistant Administrator Diversion Control Division DEA before the Committee on the Judiciary United States Senate

Diciembre 17, 2019
Hearing Entitled “Tackling the Opioid Crisis: A Whole-of-Government Approach” December 17, 2019
Diciembre 17, 2019
DOCUMENT
|
Publication

The Drug Situation in the Chicago Division (DIR-004-20)

Noviembre 15, 2019
The vast majority of drugs entering Chicago and the surrounding area, including fentanyl and fentanyl-related substances (FRS), heroin, cocaine, and methamphetamine, continue to be smuggled across the United States–Mexico border. Availability and abuse of these drugs is high, with opioids being the most prevalent in major cities and methamphetamine in...
Noviembre 15, 2019
DOCUMENT
|
Publication

Laboratory Operations Manual

Noviembre 15, 2019
This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is October 07, 2019 to June 20, 2021 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document...
Noviembre 15, 2019
DOCUMENT
|
Publication

Fentanyl Signature Profiling Program Report

Octubre 28, 2019
The Fentanyl Signature Profiling Program (FSPP) performs in-depth chemical analyses on fentanyl and fentanyl-related exhibits obtained from seizures made throughout the United States. This report details the results and conclusions derived from these analyses that are reported on a quarterly basis. FSPP data is not intended to reflect U.S. market...
Octubre 28, 2019
DOCUMENT
|
Publication

Prevenir El Uso De Marihuana Entre Adolescentes Y Adultos Jóvenes

Octubre 25, 2019
Prevenir El Uso De Marihuana Entre Adolescentes Y Adultos Jóvenes (Preventing Marijuana use in Youth and Young Adults)
Octubre 25, 2019
DOCUMENT
|
Publication

Analysis of Drugs Manual

Octubre 23, 2019
This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is October 23, 2019 to March 28, 2021 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document...
Octubre 23, 2019
DOCUMENT
|
Publication

Fentanyl in Chicago – By the Numbers

Octubre 18, 2019
The Drug Enforcement Administration (DEA) Chicago Field Division (CFD) conducted a study of all exhibits containing fentanyl and/or fentanyl-related substances (FRS) acquired within the CFD’s area of responsibility (AOR) between fiscal year (FY) 2015 and FY 2019 up to May 30, 2019. The CFD AOR includes the States of Illinois...
Octubre 18, 2019

Paginación

  • Primera página «
  • Anterior
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster